Avantor, Inc. (AVG)
XSTU
Closed
Oct 9, 2026
Day's Range
13.5752 wk Range
6.40Overview - AVG - Avantor, Inc.
Key Statistics
Valuation
Enterprise Value
10.97B
P/E (Trailing)
‪11.14‬
PEG Ratio
‪-0.33‬
Price / Sales (TTM)
‪1.37‬
Price / Book
‪1.84‬
EV / EBITDA
‪13.27‬
Profitability
Gross Margin
‪31.73%‬
Profit Margin
‪-8.80%‬
Operating Margin
‪7.16%‬
Return on Assets
‪2.69%‬
Return on Equity
‪-9.70%‬
Ownership
Shares Outstanding
676.50M
Float
657.80M
Held by Insiders
‪1.52%‬
Held by Institutions
‪105.33%‬
Price stats
Beta
‪0.89‬
50-Day Avg
‪12.07‬
200-Day Avg
‪9.09‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AVG - Avantor, Inc.
Peers - AVG - Avantor, Inc.
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on XSTU.
- AVGXSTUAvantor, Inc.8.99BMarket Cap+25.09%52-week change11.15P/E (Trailing)‪-8.80%‬Profit Margin
- 2U3XSTUAlcon Inc.31.35BMarket Cap-13.34%52-week change95.44P/E (Trailing)‪55.23%‬Profit Margin
- KB7XSTUSolventum Corporation13.37BMarket Cap+22.19%52-week change10.90P/E (Trailing)‪17.25%‬Profit Margin
- BTLXSTUBaxter International Inc.7.88BMarket Cap+7.55%52-week change-10.97P/E (Trailing)‪30.05%‬Profit Margin
- H3QXSTUDynavox Group AB (publ)701.62MMarket Cap-57.75%52-week change35.13P/E (Trailing)‪8.84%‬Profit Margin
Profile Summary - AVG - Avantor, Inc.
About
Avantor, Inc. is a global life science tools and advanced technology company that supplies mission-critical products and services to customers in biopharma, healthcare, education and government, and applied materials industries. Its portfolio includes laboratory chemicals, reagents, consumables, equipment,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
